• Users Online: 1079
  • Print this page
  • Email this page
 
REVIEW ARTICLE
Ahead of Print

Macular laser photocoagulation in the management of diabetic macular edema: Still relevant in 2020?


1 Department of Ophthalmology, Jose de San Martin Clinics Hospital, Universidad de Buenos Aires, Buenos Aires, Argentina
2 Department of Ophthalmology, Jose de San Martin Clinics Hospital, College of Engineering, Cornell University, Ithaca, NY, USA; Macula, Vitreous and Retina Associates of Costa Rica, San José, Costa Rica
3 Macula, Vitreous and Retina Associates of Costa Rica, San José, Costa Rica
4 Macula, Vitreous and Retina Associates of Costa Rica, San José, Costa Rica; Illinois Eye and Ear Infirmary, University of Illinois, Chicago, IL, USA

Correspondence Address:
Lihteh Wu,
Asociados de Mácula, Vitreoy Retina de Costa Rica, Primer Piso, Torre Mercedes, Paseo Colón, San José,

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjo.tjo_16_20

Macular laser photocoagulation (MLP) is inferior to intravitreal vascular endothelial growth factor (VEGF) inhibitors in the treatment of center-involved diabetic macular edema (DME). Ultra-widefield fluorescein angiography-guided laser photocoagulation to presumed ischemic areas of the peripheral retina or MLP do not reduce the treatment burden nor improve the visual outcomes of eyes treated with anti-VEGF drugs. Destruction of retinal tissue is not necessary to induce a therapeutic response in DME. Modern lasers are capable of producing invisible laser “burns” that do not destroy the targeted tissue using micropulse subthreshold (ST) mode where the laser's duty cycle is modified or alternatively selective retinal therapy (SRT) where ultrashort pulses of continuous wave laser selectively target the RPE. The best results with micropulse ST laser are obtained in eyes with a central macular thickness ≤400 μm. Eyes need to be treated in a continuous manner with no spaces between burns in the edematous area. Micropulse ST-MLP downregulates inflammatory biomarkers produced by activated microglial cells and Müller cells. Micropulse ST-MLP may reduce the anti-VEGF injection burden in DME. In SRT, the diseased RPE is targeted and heated with the laser with the hope that the adjacent RPE migrates and proliferates into these areas to heal the diseased RPE. There is much less experience with SRT, but the results are promising and deserve further study.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Zas M
    -  Cotic M
    -  Wu M
    -  Wu A
    -  Wu L
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed55    
    PDF Downloaded3    

Recommend this journal